Genetic engineering of mesenchymal stem cells and its application in human disease therapy.
Repository Usage Stats
The use of stem cells for tissue regeneration and repair is advancing both at the bench and bedside. Stem cells isolated from bone marrow are currently being tested for their therapeutic potential in a variety of clinical conditions including cardiovascular injury, kidney failure, cancer, and neurological and bone disorders. Despite the advantages, stem cell therapy is still limited by low survival, engraftment, and homing to damage area as well as inefficiencies in differentiating into fully functional tissues. Genetic engineering of mesenchymal stem cells is being explored as a means to circumvent some of these problems. This review presents the current understanding of the use of genetically engineered mesenchymal stem cells in human disease therapy with emphasis on genetic modifications aimed to improve survival, homing, angiogenesis, and heart function after myocardial infarction. Advancements in other disease areas are also discussed.
SubjectBone Marrow Transplantation
Clinical Trials as Topic
Mesenchymal Stem Cell Transplantation
Mesenchymal Stromal Cells
Nervous System Diseases
Published Version (Please cite this version)10.1089/hum.2010.165
Publication InfoHodgkinson, Conrad P; Gomez, José A; Mirotsou, Maria; & Dzau, Victor J (2010). Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther, 21(11). pp. 1513-1526. 10.1089/hum.2010.165. Retrieved from https://hdl.handle.net/10161/3377.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
James B. Duke Distinguished Professor of Medicine
Assistant Professor in Medicine
Alphabetical list of authors with Scholars@Duke profiles.